WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the Drug Product 3 ("DP3") facility at the Wuxi...
Hence then, the article about wuxi xdc achieves gmp release of newly launched dp3 facility at wuxi site scaling further drug product manufacturing capacity was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity )
Also on site :
- Sean Hogan’s ‘The Dark Gets In’ Boarded for Worldwide Sales by Blue Finch Films Ahead of Beyond Fest Bow (EXCLUSIVE)
- Nicholas Sparks Helped Vote a Serial-Killer Drama Into the 100 Best TV Shows of the Century; the ‘Notebook’ Author Was Not the Only Famous Voter With a Surprising Ballot
- R.E.M. Reissues Its Second Album 42 Years Later — And the Limited-Quantity Pressing Could Sell Out Fast